vTv Therapeutics Inc expected to post a loss of 82 cents a share - Earnings Preview

vTv Therapeutics

05/08/2025 24:31

vTv Therapeutics Inc VTVT.OQ VTVT.O is expected to  report resultson August 6 (estimated) for the period ending June 30 2025

​LSEG's mean analyst estimate for vTv Therapeutics Inc is for a loss of 82 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for vTv Therapeutics Inc is $35.50, about 59.2% above its last closing price of $14.47

This summary was machine generated August 4 at 23:31 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)